Pharmaceutical raw material identification
by Bruker Optics Inc.
This white paper by Bruker Optics Inc. explains pharmaceutical raw material identification using near-infrared (NIR) spectroscopy. Pharmaceutical companies often deal with a large number of raw materials and, without careful monitoring, confusion between similar or mislabeled substances can easily occur. In addition, before they can be used in the production process, incoming raw materials may also have to be tested to see that they meet certain specifications.
Bruker Optics explains two steps of initial quality analysis: identification and quantitative analysis. For both steps, NIR spectroscopy has proven to be a powerful tool. The paper describes qualitative analysis, measurement options and implementation of pharmaceutical raw material identification.
| Published: | 2006 |
| Format: | |
| Length: | 2 pages |
| Type: | White paper |
| Language: | English |
